Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Endomag
Cambridge, England, United Kingdomendomag.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Endomag’s technologies—including the Sentimag platform, Magseed marker, and Magtrace tracer—are commercially available and have been used in over 500,000 procedures globally. Clinical studies demonstrate high accuracy in tumor localization and sentinel lymph node identification, reducing unnecessary surgeries and improving outcomes for breast cancer patients.
- Therapeutic areas
- Oncology
- Modalities
- DeviceNanoparticle
- Industry
- Surgical Medical Devices
02
Partnerships
Leica Biosystems (North America distribution)Sysmex Corporation (Europe distribution)Hologic (parent/distribution US & Canada)
Beyond the preview
Go deeper on Endomag.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Endomag.